Stratasys Ltd. (NASDAQ: SSYS), a manufacturer of 3D printers and materials for personal use, prototyping and production, today announced that the company has closed its previously announced public offering. The company sold 5,175,000 ordinary shares at a public offering price of $93.00 per share, with net offering proceeds to Stratasys approximating $462.8 million, after deducting underwriting discounts and commissions and other estimated offering expenses. J.P. Morgan acted as sole book-running manager for the offering, and Piper Jaffray, Morgan Stanley, BofA Merrill Lynch, and Needham & Company acted as co-managers for the offering.
A registration statement relating to the ordinary shares offered in this offering has been filed with the Securities and Exchange Commission (the “SEC”). A final prospectus supplement relating to the offering has also been filed with the SEC. Copies of the final prospectus supplement relating to these securities may be obtained by visiting the SEC’s website at www.sec.gov or from J.P. Morgan Securities LLC c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York, NY 11717 or by calling toll-free at (866) 803-9204.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction.
About Stratasys Ltd.
Stratasys Ltd. is the corporate entity formed in 2012 by the merger of 3D printing companies Stratasys, Inc. and Objet Ltd., based in Minneapolis, Minn. and Rehovot, Israel. Stratasys manufactures 3D printers and materials for personal use, prototyping and production. Systems include entry-level desktop 3D printers for personal use and idea development, a range of systems for prototyping, and large production systems for direct digital manufacturing.
Cautionary Information Regarding Forward Looking Statements
The statements in this press release regarding Stratasys’s expectations with respect to the public offering are forward-looking statements that are subject to significant risks and uncertainties, and actual results could differ materially from those projected. These risks and uncertainties include, without limitation, risks and uncertainties related to market conditions and satisfaction of customary closing conditions related to the public offering. There can be no assurance that Stratasys will be able to complete the public offering on the anticipated terms, or at all. The forward-looking statements in this release speak only as of this date, and Stratasys disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.
|Stratasys Ltd. Announces Pricing of Public Offering of Ordinary Shares ()|
|Supercom Ltd. Announces Closing of Public Offering of Ordinary Shares (2013/12/24)|
|Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares ()|
|Idera Pharmaceuticals Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants (2014/2/10)|
|Advaxis Announces Closing of Public Offering of Common Stock and Warrants (2013/10/22)|
|Advaxis Announces Closing of Public Offering of Common Stock (2014/3/31)|
|Power Solutions International, Inc. Announces Closing of Public Offering ()|
|Opexa Therapeutics, Inc. Announces Closing of Public Offering of Common Stock (2013/8/13)|
|Neonode Announces Closing of Public Offering of Common Stock Including Full Exercise of Over-Allotment Option ()|
|Acceleron Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares (2014/1/28)|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.